Therapeutic banner
Therapeutic banner

Acute Hepatic Porphyria (AHP)

View the latest scientific data presented at congress events in the past 2 years and discover peer-reviewed publications related to AHP.
The information on this page pertains to select congress and publication resources. It is not intended to serve as a comprehensive list of all congress and publications resources.

Publications

Acute Hepatic Porphyria (AHP)

Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial

Journal of Hepatology

Author(s)

David J Kuter, Herbert L Bonkovsky, Susana Monroy, et al

Acute Hepatic Porphyria (AHP)

Pharmacokinetic-Pharmacodynamic Model of Urinary δ-Aminolevulinic Acid Reduction After Givosiran Treatment in Patients with Acute Hepatic Porphyria

CPT: Pharmacometrics & Systems Pharmacology

Author(s)

Jongtae Lee, Megan Melch, Gabriel J Robbie

Acute Hepatic Porphyria (AHP)

Population Pharmacokinetic Analysis of the RNAi Therapeutic Givosiran in Patients with Acute Hepatic Porphyria

Clinical Pharmacokinetics

Author(s)

Megan Melch, Jongtae Lee, Claudia Jomphe, et al

Acute Hepatic Porphyria (AHP)

EXPLORE B: A prospective, long-term natural history study of patients with acute hepatic porphyria with chronic symptoms

Journal of Inherited Metabolic Disease

Author(s)

David Cassiman, Raili Kauppinen, Susana Monroy

Acute Hepatic Porphyria (AHP)

Hyperhomocysteinemia in acute hepatic porphyria (AHP) and implications for treatment with givosiran

Expert Review of Gastroenterology & Hepatology

Author(s)

Paolo Ventura, Eliane Sardh, Nicola Longo, et al